Everything you need to know about supplements and what they do for you.
Learn about more than 100 medications for arthritis and related diseases.
Get the practical information you need to live better with arthritis delivered straight to your inbox!
How to reduce pain, find the right treatments and live better with arthritis. [Bi-weekly]
Fitness + Nutrition
Get weight-loss tips, arthritis-friendly recipes and ways to exercise safely. [Bi-weekly]
Mind, Body, Spirit
Find arthritis care tips, inspirational stories and Arthritis Foundation news. [Monthly]
Beyond the basics of rheumatoid arthritis: research, news and treatment. [Monthly]
Find out how pediatric rheumatologists are treating juvenile arthritis and why early and aggressive is best.
Already approved for adults with rheumatoid arthritis, Actemra is now FDA approved to treat kids with a rare form of the disease.
Adalimumab, Abatacept receive FDA approval for kids.
Actemra and Ilaris could be “game changers.”
Two new studies back up previous research and found no link between an increased risk of cancer and anti-TNFs.
A new study finds this class of biologic drugs doesn’t raise the risk of cancer in juvenile idopathic arthritis.
A new analysis suggests they may be equally effective in juvenile idiopathic arthritis.
New data shows kids with juvenile idiopathic arthritis have four times the cancer risk and treatment doesn’t appear to be to blame.
FDA orders stronger warnings for some biologic drugs used to treat juvenile arthritis after evidence reveals increased cancer risks in children.
A broad spectrum of JA treatments is available, from medication and natural therapies to surgery.
Arthritis Today Magazine
Subscribe and Receive
a FREE Drug Guide
Just For Kids
A website for kids, tweens, and teens with arthritisclick here
Looking for a quick definition of a term?view the glossary